Colombia Sessions: Contest for Young Interventionists

Sponsored by Abbott Vascular LATAM

34th SOLACI Regional Sessions – 11° Andrean Region.

October 5th and 6th, 2017.
Bogotá, Colombia.


Case Submission: “Fostering Hemodynamics among Young Cardiologists”.

It is with great pleasure that we hereby invite all young Latin American cardiologists specializing in hemodynamics to submit relevant clinical cases to the next SOLACI Sessions, Bogotá, Colombia, to be held on October 5th and 6th, 2017.

Participants will be competing for the “best case” prize, which consists of complete coverage to attend to a SOLACI Session, including air fare, accommodation and registration. Winner will have the chance to choose amongst an upcoming SOLACI Session.

 

Submitted cases must be of educational value and must pertain to the field of interventional cardiology.

 

All cases will be initially evaluated by the appointed committee and shortlisted to the best 8, which shall be presented orally during our sessions. During these presentations, a second complementary evaluation will decide on the winner.

 

Case submission deadline: September 21st, 2017.

 

 Submission Criteria and Specifications:

 

  • Case submission is meant for young Latin American interventional cardiologists and topics include: adult peripheral vascular and structural heart interventional cardiology.

 

  • In each case only one interventionist can sign. Being a fellow cardiologist or interventionist is not required.

 

  • Attach a letter of recommendation from the Chief of the Hemodynamic Service you belong to.

 

  • Send a Word file with your case description, no longer than 300 words, font size 11.

 

  • Send a complementary Power Point file with your case presentation. Even though you may use videos for your oral presentation during our sessions (up to 5), this initial file may only include up to 5 pictures only.

 

  • One cardiologist may present more than one case. If such were the case, they should be sent separately.

 

  • Cases shall be submitted via this 

 

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...